Shashank Sharma

Performance-driven international business development professional with nearly 15 years of experience in the biopharmaceutical large molecule industry. Specializes in the CRO/CDMO service industry, managing diverse portfolios including mAbs, ADCs, fusion biologics, peptides, polypeptides, liposomes, and oligonucleotides. Expertise extends to ATPMs such as mRNA, LNPs, and AAVs. Proven track record in new client establishment and global strategic expansion. Skilled in international business development and strategy planning. Focuses on sales management, business negotiations, and building relationships with global pharmaceutical and biopharmaceutical clients. Strong analytical and technical knowledge combined with revenue-driven business management skills. Provides effective customer technical service support and develops winning business proposals. Represents the company at major exhibitions and conferences on international platforms for developing new business opportunities. Actively contributes to publishing white papers and research articles to expand industry reach.

• Achieved consistently year on year targets both on sales and revenue front along with making sure the business keeps growing, controlling cost expenditure and maintaining profitability.
• Significant increase in client base by taping regions and countries which were not explored in past along with designing strategy to make sure current business with existing client is retained and grows, adding new client regularly so that around 20-25% of business is generated from new clients base and in background keep trying to regain lost client which was lost historically.
• Collaborated with Intercompany global teams to collectively enhancing overall capability and extended client and working together to increase overall business turnover.
• Leading product campaigns to establish new portfolio areas like ADCs and conjugated or fusion molecules.
• Developing product and client customized business proposal to ensure end to end services are provided keeping in mind the regulatory expectation and diversity in product type like mAbs, ADCs, Peptides, Oligonucleotides and so on.

High-Dimensional Data Analysis: a course of study offered by HarvardX, an online learning initiative of Harvard University, Aug 2021.